title: [Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].
authors: Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España. Electronic address: agueda_88@hotmail.com.
authors: Águeda
authors: Á
authors: Prior-Español
authors: Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.
authors: Melania
authors: M
authors: Martínez-Morillo
authors: Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.
authors: Anne
authors: A
authors: Riveros-Frutos
authors: Servicio de Reumatología, Hospital Universitario Germans Trias i Pujol, Barcelona, España.
authors: Alejandro
authors: A
authors: Olivé
mesh_terms: D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008171:Lung Diseases / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012074:Remission Induction; D000069283:Rituximab / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D000069283:Rituximab; D006886:Hydroxychloroquine; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone